Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

7 treatments under study, led by Tornier Ascend Flex Stem

Research Leaders

10 sponsors active, led by Medacta International SA

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Recruiting3
Completed1
Active Not Recruiting1
Not Yet Recruiting1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Tornier Ascend Flex Stem1
  • Glenohumeral Injection1
  • Total Shoulder Arthroplasty1
  • Alliance Glenoid1
  • Tornier Perform Stem Reverse1

Active Sponsors

  • Medacta International SA1
  • DePuy Synthes1
  • Vani Sabesan1
  • Corewell Health East1
  • Stryker Trauma and Extremities1

Top Investigators

Related Conditions

  • Cuff Tear Arthropathy1
  • Arthroplasty Replacement Shoulder1
  • Rotator Cuff Arthropathy1
  • Shoulder Fractures1
  • Shoulder Arthritis Osteoarthritis1

Activity Timeline